埃拉格卢西布 (前9 - ING-41) 具有强大的抗淋巴瘤特性,不能归因于GSK3抑制

Josh T Coats1, Sudhir Tauro2, Calum Sutherland3

  • 1Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.

概括

埃尔拉格卢西布可能会出现.